EFCAB5 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-10768
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human EFCAB5. Peptide sequence TEPNSPQDSKSMELEANVKLVRDILKAVILFFHPELEFSSDFGSWDKCKF
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
151 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for EFCAB5 Antibody
Western Blot: EFCAB5 Antibody [NBP3-10768]
Western Blot: EFCAB5 Antibody [NBP3-10768] - Western blot analysis of EFCAB5 in ACHN Whole cell lysates. Antibody dilution at 1.0ug/mlApplications for EFCAB5 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: EFCAB5
Alternate Names
EF-hand calcium binding domain 5, EF-hand calcium-binding domain-containing protein 5, FLJ46247
Gene Symbol
EFCAB5
Additional EFCAB5 Products
Product Specific Notices for EFCAB5 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...